Citigroup’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.95M Sell
180,973
-88,094
-33% -$4.84M ﹤0.01% 1005
2025
Q1
$19M Buy
269,067
+50,613
+23% +$3.58M 0.01% 729
2024
Q4
$14.4M Buy
218,454
+11,254
+5% +$740K 0.01% 794
2024
Q3
$14.6M Buy
207,200
+37,517
+22% +$2.64M 0.01% 787
2024
Q2
$14M Sell
169,683
-52,691
-24% -$4.34M 0.01% 765
2024
Q1
$19.4M Buy
222,374
+31,582
+17% +$2.76M 0.01% 632
2023
Q4
$18.4M Sell
190,792
-18,316
-9% -$1.77M 0.01% 615
2023
Q3
$18.5M Sell
209,108
-7,746
-4% -$685K 0.01% 568
2023
Q2
$18.8M Sell
216,854
-52,752
-20% -$4.57M 0.01% 609
2023
Q1
$26.2M Buy
269,606
+90,762
+51% +$8.83M 0.02% 499
2022
Q4
$18.5M Sell
178,844
-33,171
-16% -$3.43M 0.01% 592
2022
Q3
$18M Buy
212,015
+32,579
+18% +$2.76M 0.01% 588
2022
Q2
$14.9M Buy
179,436
+58,316
+48% +$4.83M 0.01% 676
2022
Q1
$9.34M Sell
121,120
-194,424
-62% -$15M 0.01% 935
2021
Q4
$27.9M Buy
315,544
+76,314
+32% +$6.74M 0.01% 560
2021
Q3
$18.5M Sell
239,230
-14,603
-6% -$1.13M 0.01% 730
2021
Q2
$21.2M Sell
253,833
-7,177
-3% -$599K 0.01% 724
2021
Q1
$19.7M Buy
261,010
+29,854
+13% +$2.25M 0.01% 721
2020
Q4
$20.3M Sell
231,156
-28,807
-11% -$2.53M 0.01% 660
2020
Q3
$19.8M Sell
259,963
-5,204
-2% -$396K 0.01% 570
2020
Q2
$32.7M Buy
265,167
+25,653
+11% +$3.16M 0.03% 344
2020
Q1
$20.2M Buy
239,514
+1,540
+0.6% +$130K 0.02% 420
2019
Q4
$20.1M Sell
237,974
-220
-0.1% -$18.6K 0.01% 543
2019
Q3
$16.1M Buy
238,194
+67,113
+39% +$4.52M 0.01% 611
2019
Q2
$14.7M Buy
171,081
+21,755
+15% +$1.86M 0.01% 663
2019
Q1
$13.3M Buy
149,326
+4,756
+3% +$422K 0.01% 609
2018
Q4
$12.3M Buy
144,570
+14,874
+11% +$1.27M 0.01% 618
2018
Q3
$12.6M Buy
129,696
+4,189
+3% +$406K 0.01% 622
2018
Q2
$11.8M Buy
125,507
+90,255
+256% +$8.5M 0.01% 671
2018
Q1
$2.86M Sell
35,252
-10,254
-23% -$831K ﹤0.01% 1264
2017
Q4
$4.06M Buy
45,506
+12,723
+39% +$1.13M ﹤0.01% 1080
2017
Q3
$3.05M Sell
32,783
-59,738
-65% -$5.56M ﹤0.01% 1223
2017
Q2
$8.4M Buy
92,521
+28,379
+44% +$2.58M 0.01% 708
2017
Q1
$5.63M Sell
64,142
-115,369
-64% -$10.1M 0.01% 860
2016
Q4
$14.9M Buy
179,511
+126,342
+238% +$10.5M 0.01% 496
2016
Q3
$4.92M Buy
53,169
+6,348
+14% +$587K ﹤0.01% 898
2016
Q2
$3.64M Sell
46,821
-21,902
-32% -$1.7M ﹤0.01% 961
2016
Q1
$5.67M Sell
68,723
-1,929
-3% -$159K 0.01% 768
2015
Q4
$7.4M Sell
70,652
-55,871
-44% -$5.85M 0.01% 698
2015
Q3
$13.3M Sell
126,523
-5,819
-4% -$613K 0.01% 472
2015
Q2
$18.1M Buy
132,342
+50,516
+62% +$6.91M 0.02% 402
2015
Q1
$10.2M Buy
81,826
+31,251
+62% +$3.89M 0.01% 573
2014
Q4
$4.57M Sell
50,575
-59,417
-54% -$5.37M ﹤0.01% 875
2014
Q3
$7.94M Buy
109,992
+31,496
+40% +$2.27M 0.01% 676
2014
Q2
$4.88M Buy
78,496
+47,245
+151% +$2.94M ﹤0.01% 897
2014
Q1
$2.13M Buy
31,251
+6,054
+24% +$413K ﹤0.01% 1189
2013
Q4
$1.77M Sell
25,197
-20,442
-45% -$1.44M ﹤0.01% 1449
2013
Q3
$3.3M Buy
45,639
+18,160
+66% +$1.31M ﹤0.01% 1052
2013
Q2
$1.53M Buy
+27,479
New +$1.53M ﹤0.01% 1374